CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE

23486 reported adverse events

Drug classes: Estrogen [EPC]

These side effects are most commonly reported by patients taking CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE:

# Side effect Count
0 BREAST CANCER 7889
1 BREAST CANCER FEMALE 5791
2 BREAST CANCER METASTATIC 1505
3 DRUG INEFFECTIVE 738
4 CEREBROVASCULAR ACCIDENT 502
5 DEPRESSION 478
6 HEADACHE 426
7 ANXIETY 418
8 NAUSEA 414
9 DEEP VEIN THROMBOSIS 397
See all common reactions for CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE

CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONTRALATERAL BREAST CANCER 90 0.4369
1 PROGESTERONE RECEPTOR ASSAY POSITIVE 333 0.3565
2 OESTROGEN RECEPTOR ASSAY POSITIVE 374 0.3298
3 MALIGNANT BREAST LUMP REMOVAL 40 0.2985
4 BREAST CANCER FEMALE 5791 0.2166
5 BREAST CANCER METASTATIC 1505 0.1400
6 BREAST OPERATION 103 0.1259
7 OVARIAN CANCER METASTATIC 100 0.1176
8 BREAST CANCER 7889 0.0846
9 BREAST HYPERPLASIA 29 0.0824
See all enriched reactions for CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE